| Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation C Oncken, D Gonzales, M Nides, S Rennard, E Watsky, CB Billing, ... Archives of internal medicine 166 (15), 1571-1577, 2006 | 509 | 2006 |
| A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition EP Harrigan, JJ Miceli, R Anziano, E Watsky, KR Reeves, NR Cutler, ... Journal of clinical psychopharmacology 24 (1), 62-69, 2004 | 480 | 2004 |
| The QT interval MM Bednar, EP Harrigan, RJ Anziano, AJ Camm, JN Ruskin Progress in cardiovascular diseases 43 (5), 1-45, 2001 | 410 | 2001 |
| Model‐based drug development: a rational approach to efficiently accelerate drug development PA Milligan, MJ Brown, B Marchant, SW Martin, PH Van Der Graaf, ... Clinical Pharmacology & Therapeutics 93 (6), 502-514, 2013 | 246 | 2013 |
| The effect of carbamazepine on the steady‐state pharmacokinetics of ziprasidone in healthy volunteers JJ Miceli, RJ Anziano, L Robarge, RA Hansen, A Laurent British Journal of Clinical Pharmacology 49 (S1), 65-70, 2000 | 160 | 2000 |
| Disease progression model for cognitive deterioration from Alzheimer's Disease Neuroimaging Initiative database K Ito, B Corrigan, Q Zhao, J French, R Miller, H Soares, E Katz, T Nicholas, ... Alzheimer's & Dementia 7 (2), 151-160, 2011 | 157 | 2011 |
| Thorough QT study with recommended and supratherapeutic doses of tolterodine BK Malhotra, P Glue, K Sweeney, R Anziano, J Mancuso, P Wicker Clinical Pharmacology & Therapeutics 81 (3), 377-385, 2007 | 89 | 2007 |
| The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function G Everson, KC Lasseter, KE Anderson, LA Bauer, RL Carithens Jr, ... British Journal of Clinical Pharmacology 49 (S1), 21-26, 2000 | 68 | 2000 |
| Evaluation of the Intelisite capsule to deliver theophylline and frusemide tablets to the small intestine and colon NJ Clear, A Milton, M Humphrey, BT Henry, M Wulff, DJ Nichols, ... European journal of pharmaceutical sciences 13 (4), 375-384, 2001 | 63 | 2001 |
| Understanding placebo responses in Alzheimer's disease clinical trials from the literature meta-data and CAMD database K Ito, B Corrigan, K Romero, R Anziano, J Neville, D Stephenson, ... Journal of Alzheimer's Disease 37 (1), 173-183, 2013 | 55 | 2013 |
| The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function F Aweeka, D Jayesekara, M Horton, S Swan, L Lambrecht, KD Wilner, ... British Journal of Clinical Pharmacology 49 (S1), 27-33, 2000 | 54 | 2000 |
| The anxiolytic effect of the novel antipsychotic ziprasidone compared with diazepam in subjects anxious before dental surgery KD Wilner, RJ Anziano, AC Johnson, JJ Miceli, JR Fricke, CK Titus Journal of clinical psychopharmacology 22 (2), 206-210, 2002 | 49 | 2002 |
| Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with … JJ Miceli, TG Tensfeldt, T Shiovitz, RJ Anziano, C O'Gorman, RH Harrigan Clinical therapeutics 32 (3), 472-491, 2010 | 43 | 2010 |
| Effects of oral ziprasidone and oral haloperidol on QTc interval in patients with schizophrenia or schizoaffective disorder JJ Miceli, TG Tensfeldt, T Shiovitz, R Anziano, C O'Gorman, RH Harrigan Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 30 (2 …, 2010 | 43 | 2010 |
| Ziprasidone and the pharmacokinetics of a combined oral contraceptive GJ Muirhead, J Harness, PR Holt, S Oliver, RJ Anziano British journal of clinical pharmacology 49 (S1), 49-56, 2000 | 38 | 2000 |
| Ziprasidone and the activity of cytochrome P450 2D6 in healthy extensive metabolizers KD Wilner, SB Demattos, RJ Anziano, G Apseloff, N Gerber British Journal of Clinical Pharmacology 49 (S1), 43-47, 2000 | 36 | 2000 |
| The effects of ziprasidone on steady‐state lithium levels and renal clearance of lithium G Apseloff, D Mullet, KD Wilner, RJ Anziano, TG Tensfeldt, SM Pelletier, ... British Journal of Clinical Pharmacology 49 (S1), 61-64, 2000 | 36 | 2000 |
| Development of a straightforward and sensitive scale for MCI and early AD clinical trials Y Huang, K Ito, CB Billing Jr, RJ Anziano, ... Alzheimer's & Dementia 11 (4), 404-414, 2015 | 22 | 2015 |
| Assessing QT variability in healthy volunteers MA Agin, DJ Kazierad, R Abel, R Anziano, CB Billing, G Layton, ... JOURNAL OF CLINICAL PHARMACOLOGY 43 (9), 1028-1028, 2003 | 22 | 2003 |
| IM ziprasidone and IM haloperidol have comparable effects on QTc at Cmax JJ Miceli, RJ Anziano, RH Swift, TG Tensfeldt, T Shiovitz Poster presented at: America Psychiatric Association annual meeting, 2002 | 11 | 2002 |
